Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03176004 · ClinicalTrials.gov registry record · NA

Attention Training to Modify Error-related Negativity and Risk for Anxiety in Adolescence

A NA study of Anxiety, sponsored by Florida State University.

Completed
Registry status
NA
Development phase
600
Enrollment target
2
Study locations

NCT03176004: Completed NA study of Anxiety, sponsored by Florida State University.

NCT03176004 is a NA study of Anxiety that has completed, run by Florida State University. The registered enrollment target is 600 participants, above the 438-participant average among 364 other Anxiety trials with a reported enrollment target (37% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03176004, a NA study of Anxiety, has completed, sponsored by Florida State University.

COMPLETED
Registry status
NA
Development phase
600 participants
Enrollment target
2
Study locations

Study Summary

This is a multi-site study to examine error-related brain activity (i.e., the error-related negativity) and anxiety symptoms in 11 to 14 year-olds (N=600) at two time points separated by two years. The study examines the degree to which error-related negativity can predict anxiety prospectively over two years, and whether a computerized game that alters attention to threat can alter error-related negativity and trajectories of anxiety.

Primary Outcome

Symptoms of Anxiety on the Screen for Child Anxiety Related Emotional Disorders (SCARED)

Conditions Studied

Interventions

  • OTHER Attention Bias Modification

Study Locations (2)

California

  • San Diego State University - San Diego

Florida

  • Florida State University - Tallahassee

Trial Details

FieldValue
Enrollment Target 600 participants
Start Date 2016-10
Est. Completion 2021-12-01
Phase NA
Florida State University

219 total trials

What the finished NCT03176004 record still lists

NCT03176004 is an interventional study that assigns participants to a tested intervention. The registered 600 participants enrollment target is mid-sized for trials with a published cap, above the 438-participant average among 364 other Anxiety trials with a reported enrollment target (37% higher).

The record links to 1 condition, with Anxiety appearing as the primary indexed condition, and to 1 intervention - of which Attention Bias Modification is the first listed.

NCT03176004 reports a single indexed study location in California, Florida.

Frequently Asked Questions

What is clinical trial NCT03176004 about?

NCT03176004 is a clinical study titled "Attention Training to Modify Error-related Negativity and Risk for Anxiety in Adolescence". This is a multi-site study to examine error-related brain activity (i.e., the error-related negativity) and anxiety symptoms in 11 to 14 year-olds (N=600) at two time points separated by two years. The study examines the degree to which error-related negativity can predict anxiety prospectively over...

What is the current status of trial NCT03176004?

This trial is currently completed. It is a NA study. The enrollment target is 600 participants. The study started on 2016-10. Estimated completion is 2021-12-01.

What conditions does trial NCT03176004 study?

This clinical trial studies the following conditions: Anxiety.

What interventions are being tested in trial NCT03176004?

The interventions under investigation include: Attention Bias Modification (OTHER).

Who is sponsoring clinical trial NCT03176004?

This trial is sponsored by Florida State University, which has 219 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03176004 being conducted?

This trial has 2 study locations across California, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anxiety

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03176004's enrollment target sits among peer trials

600 24th of 364 higher than 340 of 364 other Anxiety trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Anxiety trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00004317 · 600 participants · Phase 4

    Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis

  • NCT00209235 · 600 participants · NA

    Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments

  • NCT01473784 · 600 participants · NA

    Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck

  • NCT01866371 · 600 participants

    High Resolution Retinal Imaging

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT03176004, the US trial registry maintained by the National Library of Medicine. NCT03176004 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.